Canadian Cardiovascular Society updates atrial fibrillation guidelines

Sarah Sipek | | Cardiovascular Business | Interventional Cardiology

Canadian physicians now have an updated set of guidelines for managing patients suffering from atrial fibrillation (AF).

The Canadian Journal of Cardiology released the 2016 Focused Update to the Canadian Cardiovascular Society’s (CCS) guidelines on AF. An important change involves patients who suffer from coronary artery disease in addition to AF. Non-vitamin K antagonists oral anticoagulants are the preferred treatment over warfarin.

"The development of guidelines has been a key activity of the CCS for over a decade," co-chairs Laurent Macle, MD, of the Montreal Heart Institute, Université de Montréal, and Atul Verma MD, of the Southlake Regional Health Centre. "Well-developed guidelines have the potential to improve the quality of cardiovascular care, lead to better patient outcomes, improve cost-effectiveness, and highlight areas for further research."

The original guidelines were developed back in 2010 by the CCS and are reviewed every two years. This Focused Update makes specific recommendations based on a patient’s risk of stroke.

For example, in patients with AF with an indication for primary CAD prevention or stable CAD or arterial vascular disease, the selection of antithrombotic therapy should be based on his risk of stroke.

An updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update, are provided in an online supplement.

Sarah Sipek

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."